Cite
Campbell CL, Snell TK, Bennett S, et al. Safety study of Rift Valley Fever human vaccine candidate (DDVax) in mosquitoes. Transbound Emerg Dis. 2021;doi: 10.1111/tbed.14415.
Campbell, C. L., Snell, T. K., Bennett, S., Wyckoff, J. H., Heaslip, D., Flatt, J., Harris, E. K., Hartman, D. A., Lian, E., Bird, B. H., Stenglein, M. D., Bowen, R. A., & Kading, R. C. (2021). Safety study of Rift Valley Fever human vaccine candidate (DDVax) in mosquitoes. Transboundary and emerging diseases, . https://doi.org/10.1111/tbed.14415
Campbell, Corey L, et al. "Safety study of Rift Valley Fever human vaccine candidate (DDVax) in mosquitoes." Transboundary and emerging diseases vol. (2021). doi: https://doi.org/10.1111/tbed.14415
Campbell CL, Snell TK, Bennett S, Wyckoff JH, Heaslip D, Flatt J, Harris EK, Hartman DA, Lian E, Bird BH, Stenglein MD, Bowen RA, Kading RC. Safety study of Rift Valley Fever human vaccine candidate (DDVax) in mosquitoes. Transbound Emerg Dis. 2021 Dec 10; doi: 10.1111/tbed.14415. Epub 2021 Dec 10. PMID: 34890118.
Copy
Download .nbib